Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.

Jiang Z, Slater CM, Zhou Y, Devarajan K, Ruth KJ, Li Y, Cai KQ, Daly M, Chen X.

Breast Cancer Res. 2017 May 30;19(1):62. doi: 10.1186/s13058-017-0853-2.

2.

Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma.

Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H.

Oncotarget. 2017 Jun 6;8(23):37423-37434. doi: 10.18632/oncotarget.16965.

3.

Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence.

Franco-Barraza J, Francescone R, Luong T, Shah N, Madhani R, Cukierman G, Dulaimi E, Devarajan K, Egleston BL, Nicolas E, Katherine Alpaugh R, Malik R, Uzzo RG, Hoffman JP, Golemis EA, Cukierman E.

Elife. 2017 Jan 31;6. pii: e20600. doi: 10.7554/eLife.20600.

4.

Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma.

Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, Liao L, Cho EA, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H.

PLoS One. 2016 Oct 20;11(10):e0164554. doi: 10.1371/journal.pone.0164554. eCollection 2016.

5.

Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.

Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, Yeung AT, Clapper ML, Uzzo RG, Henske EP, Ricketts CJ, Vocke CD, Linehan WM, Testa JR, Bellacosa A, Kopelovich L, Knudson AG.

Oncotarget. 2017 Mar 14;8(11):17628-17642. doi: 10.18632/oncotarget.12192.

6.

Correction: The Antsy Social Network: Determinants of Nest Structure and Arrangement in Asian Weaver Ants.

Devarajan K.

PLoS One. 2016 Jul 8;11(7):e0159284. doi: 10.1371/journal.pone.0159284. eCollection 2016.

7.

Blue light-mediated transcriptional activation and repression of gene expression in bacteria.

Jayaraman P, Devarajan K, Chua TK, Zhang H, Gunawan E, Poh CL.

Nucleic Acids Res. 2016 Aug 19;44(14):6994-7005. doi: 10.1093/nar/gkw548. Epub 2016 Jun 28.

8.

The Antsy Social Network: Determinants of Nest Structure and Arrangement in Asian Weaver Ants.

Devarajan K.

PLoS One. 2016 Jun 7;11(6):e0156681. doi: 10.1371/journal.pone.0156681. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0159284.

9.

Kinase Inhibitor Profiling Reveals Unexpected Opportunities to Inhibit Disease-Associated Mutant Kinases.

Duong-Ly KC, Devarajan K, Liang S, Horiuchi KY, Wang Y, Ma H, Peterson JR.

Cell Rep. 2016 Feb 2;14(4):772-81. doi: 10.1016/j.celrep.2015.12.080. Epub 2016 Jan 14.

10.

The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular Carcinoma.

Wang M, Devarajan K, Singal AG, Marrero JA, Dai J, Feng Z, Rinaudo JA, Srivastava S, Evans A, Hann HW, Lai Y, Yang H, Block TM, Mehta A.

Cancer Prev Res (Phila). 2016 Feb;9(2):172-9. doi: 10.1158/1940-6207.CAPR-15-0186. Epub 2015 Dec 28.

11.

Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis.

Tricarico R, Cortellino S, Riccio A, Jagmohan-Changur S, Van der Klift H, Wijnen J, Turner D, Ventura A, Rovella V, Percesepe A, Lucci-Cordisco E, Radice P, Bertario L, Pedroni M, Ponz de Leon M, Mancuso P, Devarajan K, Cai KQ, Klein-Szanto AJ, Neri G, Møller P, Viel A, Genuardi M, Fodde R, Bellacosa A.

Oncotarget. 2015 Dec 15;6(40):42892-904. doi: 10.18632/oncotarget.5740.

12.

Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience.

Vijayvergia N, Dotan E, Devarajan K, Hatahet K, Rahman F, Ricco J, Lewis B, Gupta S, Cohen SJ.

J Geriatr Oncol. 2015 Nov;6(6):454-61. doi: 10.1016/j.jgo.2015.08.001. Epub 2015 Aug 18.

13.

Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors.

Zibelman M, Wong YN, Devarajan K, Malizzia L, Corrigan A, Olszanski AJ, Denlinger CS, Roethke SK, Tetzlaff CH, Plimack ER.

Invest New Drugs. 2015 Oct;33(5):1040-7. doi: 10.1007/s10637-015-0261-3. Epub 2015 Jun 20.

14.
15.

Nonviral Reprogramming of Human Wharton's Jelly Cells Reveals Differences Between ATOH1 Homologues.

Mellott AJ, Devarajan K, Shinogle HE, Moore DS, Talata Z, Laurence JS, Forrest ML, Noji S, Tanaka E, Staecker H, Detamore MS.

Tissue Eng Part A. 2015 Jun;21(11-12):1795-809. doi: 10.1089/ten.TEA.2014.0340. Epub 2015 Apr 13.

16.

Pharmacological profiling of kinase dependency in cell lines across triple-negative breast cancer subtypes.

Fink LS, Beatty A, Devarajan K, Peri S, Peterson JR.

Mol Cancer Ther. 2015 Jan;14(1):298-306. doi: 10.1158/1535-7163.MCT-14-0529. Epub 2014 Oct 24.

17.

H3K4me3 breadth is linked to cell identity and transcriptional consistency.

Benayoun BA, Pollina EA, Ucar D, Mahmoudi S, Karra K, Wong ED, Devarajan K, Daugherty AC, Kundaje AB, Mancini E, Hitz BC, Gupta R, Rando TA, Baker JC, Snyder MP, Cherry JM, Brunet A.

Cell. 2014 Jul 31;158(3):673-88. doi: 10.1016/j.cell.2014.06.027. Erratum in: Cell. 2015 Nov 19;163(5):1281-6.

18.

Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.

Dotan E, Devarajan K, D'Silva AJ, Beck A, Kloth DD, Cohen SJ, Denlinger C.

Clin Colorectal Cancer. 2014 Sep;13(3):192-8. doi: 10.1016/j.clcc.2014.05.003. Epub 2014 Jun 26.

19.

Identifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patients.

Pape-Zambito D, Jiang Z, Wu H, Devarajan K, Slater CM, Cai KQ, Patchefsky A, Daly MB, Chen X.

PLoS One. 2014 Jun 30;9(6):e100488. doi: 10.1371/journal.pone.0100488. eCollection 2014.

20.

Risk of positive nonsentinel nodes in women with 1-2 positive sentinel nodes related to age and molecular subtype approximated by receptor status.

Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K, Anderson PR, Sigurdson ER, Goldstein LJ, Bleicher RJ.

Breast J. 2014 Jul-Aug;20(4):358-63. doi: 10.1111/tbj.12276. Epub 2014 May 26.

Supplemental Content

Loading ...
Support Center